Verapamil hydrochloride and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Verapamil hydrochloride (verapamil hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 10+ years also take Eliquis, and have Stroke.

The phase IV clinical study analyzes which people have Nosebleed when taking Verapamil hydrochloride. It is created by eHealthMe based on reports of 5,450 people who have side effects when taking Verapamil hydrochloride from the FDA, and is updated regularly.

What is Verapamil hydrochloride?

Verapamil hydrochloride has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 6,650 Verapamil hydrochloride users. Check the latest studies of Verapamil hydrochloride.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,089 drugs and 3,092 conditions by eHealthMe. Check the latest studies of Nosebleed.

On Apr, 25, 2026

5,450 people reported to have side effects when taking Verapamil hydrochloride.
Among them, 52 people (0.95%) have Nosebleed.

Could Verapamil hydrochloride cause Nosebleed?

Among these 52 people:

How long have people been on Verapamil hydrochloride when they have Nosebleed? *

Click here to view more results

What is the gender of people who have Nosebleed when taking Verapamil hydrochloride? *

Click here to view

What is the age of people who have Nosebleed when taking Verapamil hydrochloride? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Verapamil hydrochloride and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Verapamil hydrochloride:

Verapamil hydrochloride (6,650 reports)

Nosebleed treatments and more:

Nosebleed (92,075 reports)

How severe was Nosebleed and when was it recovered:

Nosebleed in Verapamil hydrochloride

Expand to all the drugs that have ingredients of verapamil hydrochloride:

Nosebleed and drugs with ingredients of verapamil hydrochloride (504 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Verapamil hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Nosebleed (2,089 drugs)

Browse all the conditions that are associated with Nosebleed:

Nosebleed (3,092 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on verapamil hydrochloride (the active ingredients of Verapamil hydrochloride) and Verapamil hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.